[go: up one dir, main page]

MX2007004736A - Composicion farmaceutica que comprende diclofenaco. - Google Patents

Composicion farmaceutica que comprende diclofenaco.

Info

Publication number
MX2007004736A
MX2007004736A MX2007004736A MX2007004736A MX2007004736A MX 2007004736 A MX2007004736 A MX 2007004736A MX 2007004736 A MX2007004736 A MX 2007004736A MX 2007004736 A MX2007004736 A MX 2007004736A MX 2007004736 A MX2007004736 A MX 2007004736A
Authority
MX
Mexico
Prior art keywords
diclofenac
pharmaceutical composition
pharmaceutical compositions
oral administration
relates
Prior art date
Application number
MX2007004736A
Other languages
English (en)
Inventor
Isabelle Rault
Stephan Meyer
Alexander Mark Schobel
Greg Slominski
Gavin Murray Spencer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35840581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007004736(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2007004736A publication Critical patent/MX2007004736A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La invencion se refiere a composiciones farmaceuticas adecuadas para la administracion oral en la forma de peliculas comestibles que comprenden diclofenaco.
MX2007004736A 2004-10-21 2005-10-20 Composicion farmaceutica que comprende diclofenaco. MX2007004736A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62070604P 2004-10-21 2004-10-21
PCT/US2005/038090 WO2006047365A1 (en) 2004-10-21 2005-10-20 Pharmaceutical composition comprising diclofenac

Publications (1)

Publication Number Publication Date
MX2007004736A true MX2007004736A (es) 2007-06-18

Family

ID=35840581

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007004736A MX2007004736A (es) 2004-10-21 2005-10-20 Composicion farmaceutica que comprende diclofenaco.

Country Status (19)

Country Link
US (1) US8911769B2 (es)
EP (1) EP1804777B1 (es)
JP (1) JP5213446B2 (es)
KR (1) KR101288162B1 (es)
CN (1) CN101043880B (es)
AR (1) AR051397A1 (es)
AU (1) AU2005299741B2 (es)
BR (1) BRPI0516238A (es)
CA (1) CA2577862C (es)
IL (1) IL182020A0 (es)
MX (1) MX2007004736A (es)
NO (1) NO20072262L (es)
NZ (1) NZ553475A (es)
PE (1) PE20060935A1 (es)
PL (1) PL1804777T3 (es)
RU (1) RU2424793C2 (es)
TW (1) TWI406680B (es)
WO (1) WO2006047365A1 (es)
ZA (1) ZA200701557B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007129706A1 (ja) * 2006-05-10 2007-11-15 Kureha Corporation 経口物を封入した可食性フィルム包装体
US8580830B2 (en) * 2006-10-02 2013-11-12 Labtec Gmbh Non-mucoadhesive film dosage forms
JP4916894B2 (ja) * 2007-01-11 2012-04-18 株式会社ツキオカ フィルム状製剤及びフィルム状製剤の製造方法
US20080286349A1 (en) * 2007-05-18 2008-11-20 Youhei Nomoto Systems, devices, and methods for passive transdermal delivery of active agents to a biological interface
MY163111A (en) * 2008-08-25 2017-08-15 Kyukyu Yakuhin Kogyo Kk Film preparation containing loperamide hydrochloride
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
WO2011108643A1 (ja) * 2010-03-03 2011-09-09 救急薬品工業株式会社 不快な味を有する薬物を含有するフィルム製剤
AU2011232408B2 (en) 2010-03-24 2015-07-30 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
JP5751868B2 (ja) * 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
JP2011207847A (ja) * 2010-03-30 2011-10-20 Nitto Denko Corp フィルム状製剤及びその製造方法
JP5555148B2 (ja) * 2010-12-10 2014-07-23 日東電工株式会社 シート状製剤及びシート状製剤の製造方法
EP2717852B1 (en) 2011-06-08 2019-05-08 LTS LOHMANN Therapie-Systeme AG Edible oral strip or wafer dosage form containing ion exchange resin for taste masking
JP5841433B2 (ja) 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
US11116769B2 (en) 2013-04-11 2021-09-14 Ctc Bio, Inc. Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer
CN105209025B (zh) * 2013-04-11 2019-06-18 西梯茜生命工学股份有限公司 包括聚乙二醇类聚合物和/或乙烯基吡咯烷酮类聚合物作为分散稳定剂的含他达拉非游离碱的膜剂形式
KR102305037B1 (ko) * 2013-05-10 2021-09-24 주식회사 씨티씨바이오 도네페질 유리염기 함유 필름 제제 및 이의 제조 방법
JP6599083B2 (ja) * 2014-03-30 2019-10-30 小林製薬株式会社 外用医薬組成物
JP6580305B2 (ja) * 2014-03-30 2019-09-25 小林製薬株式会社 外用医薬組成物
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
DE102017103346A1 (de) * 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US10882945B2 (en) 2018-03-26 2021-01-05 Medtronic, Inc. Modified polyisobutylene-based polymers, methods of making, and medical devices
US20210229881A1 (en) * 2018-05-14 2021-07-29 Rks Global Pte Ltd A dosage in film package form, a film composition and a process for preparation thereof
BR112021006027A2 (pt) 2018-11-19 2021-06-29 Jazz Pharmaceuticals Ireland Limited formulações de fármaco resistente a álcool
GB201819978D0 (en) 2018-12-07 2019-01-23 Univ Strathclyde Oral thin films
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
CN121038779A (zh) 2023-02-03 2025-11-28 特瑞斯制药公司 每晚一次的低钠羟丁酸盐组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
JPS61280423A (ja) * 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
US4855142A (en) 1987-02-27 1989-08-08 Ciba-Geigy Corporation Pharmaceutical plaster
US5256699A (en) * 1988-10-18 1993-10-26 Ciba-Geify Corporation Dispersible tablet formulation of diclofenac acid free base
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
US5637313A (en) 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
AU765526B2 (en) * 1999-08-17 2003-09-18 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
AU2003235294B2 (en) 2002-05-16 2008-04-17 Kyukyu Pharmaceutical Co., Ltd. Quickly soluble film preparations
JP2004043450A (ja) * 2002-05-16 2004-02-12 Kyukyu Yakuhin Kogyo Kk 速溶性フィルム状製剤
FR2840221B1 (fr) * 2002-06-04 2006-01-13 Backert Marie Elisabeth Cuine Film polymerique contenant des "actifs" destines a etre liberes dans un liquide
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
US20040202698A1 (en) 2003-04-02 2004-10-14 The Procter & Gamble Company Drug delivery systems comprising an encapsulated active ingredient
ITMI20032087A1 (it) * 2003-10-27 2005-04-28 Pharmafilm S R L Film autosupportanti per uso farmaceutico ed alimentare.

Also Published As

Publication number Publication date
BRPI0516238A (pt) 2008-08-26
CA2577862A1 (en) 2006-05-04
RU2424793C2 (ru) 2011-07-27
NZ553475A (en) 2010-10-29
ZA200701557B (en) 2008-08-27
US8911769B2 (en) 2014-12-16
RU2007118726A (ru) 2008-11-27
KR101288162B1 (ko) 2013-07-18
NO20072262L (no) 2007-05-14
CA2577862C (en) 2013-06-04
PL1804777T3 (pl) 2018-09-28
AR051397A1 (es) 2007-01-10
CN101043880B (zh) 2011-08-10
JP2008517935A (ja) 2008-05-29
KR20070065890A (ko) 2007-06-25
EP1804777B1 (en) 2018-05-09
TWI406680B (zh) 2013-09-01
PE20060935A1 (es) 2006-10-26
JP5213446B2 (ja) 2013-06-19
TW200621317A (en) 2006-07-01
EP1804777A1 (en) 2007-07-11
AU2005299741A1 (en) 2006-05-04
CN101043880A (zh) 2007-09-26
WO2006047365A1 (en) 2006-05-04
AU2005299741B2 (en) 2009-03-12
IL182020A0 (en) 2007-07-24
US20080003267A1 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
TW200621317A (en) Pharmaceutical composition
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
MX2009002666A (es) Compuestos de n-metilaminometil isoindol, composiciones que los comprenden y metodos que utilizan los mismos.
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
MY146969A (en) Dpp iv inhibitor formulations
ZA200801575B (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
WO2007095091A3 (en) Oral delivery of therapeutic agents using tight junction agonists
UA98804C2 (ru) Катехоламиновые производные и фармацевтическая композиция на их основе
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
MX2009010989A (es) Composiciones farmaceuticas liofilizadas y metodos de obtener y usar las mismas.
WO2008113901A3 (fr) Composition à libération prolongée de lévétiracetam et procédé de préparation.
EP1755633A4 (en) ORAL ADMINISTRATION OF PEPTIDE PHARMACEUTICAL COMPOSITIONS
WO2008075320A3 (en) Antilipidemic pharmaceutical compositions and process for preparation thereof
IL191670A0 (en) Compounds for the inhibition of apoptosis
ZA200704318B (en) Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
TN2010000243A1 (en) Pharmaceutical composition
GB0615105D0 (en) Novel compounds
GB0620619D0 (en) Novel compounds
GEP20064009B (en) Cetylpyridinium salt of an anti-inflammatory agent and armaceutical compositions containing it
TW200833375A (en) Pharmaceutical compositions
ITMI20061741A1 (it) Composizioni farmaceutiche per la somministrazione orale di sostanze proteiche
MD20040296A (ro) Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ
NO20085189L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamid-benzotaizepiner, fremstilling og anvendelse derav sammensetninger inneholdende samme

Legal Events

Date Code Title Description
FG Grant or registration
HH Correction or change in general